{"id":283127,"date":"2018-10-29T06:35:09","date_gmt":"2018-10-29T06:35:09","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=283127"},"modified":"2018-10-29T06:35:09","modified_gmt":"2018-10-29T06:35:09","slug":"community-acquired-pneumonia-cap-global-market-analysis-growth-opportunities-top-key-players-and-forecast-to-2025","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/community-acquired-pneumonia-cap-global-market-analysis-growth-opportunities-top-key-players-and-forecast-to-2025_283127.html","title":{"rendered":"Community Acquired Pneumonia (CAP) Global Market Analysis, Growth, Opportunities, Top Key Players and Forecast to 2025"},"content":{"rendered":"<div style=\" width:250px; padding:8px 10px 10px 10px; float:right;\"><a href=\"https:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2018\/10\/1540805924.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"image\" src=\"https:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2018\/10\/1540805924.jpeg\" alt=\"\" width=\"164\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\" style=\" font-weight:bold; font-style:italic;\">\n<div>&#8220;Community Acquired Pneumonia (CAP) Market&#8221;<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">WiseGuyRerports.com Presents \u201cGlobal Community Acquired Pneumonia (CAP) Market Size, Status and Forecast 2018-2025\u201d New Document to its Studies Database<\/div>\n<p>&nbsp;<\/p>\n<p><strong><a rel=\"nofollow\" href=\"https:\/\/www.wiseguyreports.com\/sample-request\/3470656-global-community-acquired-pneumonia-cap-market-size-status-and-forecast-2018-2025\">Community-acquired pneumonia (CAP)<\/a><\/strong> refers to pneumonia (any of several lung diseases) contracted by a person with little contact with the healthcare system.&nbsp;<br \/> The market of CAP treatment and diagnosis in further segmented with respect to major geographies of North America, Europe, Asia-Pacific, and Latin America.&nbsp;<br \/> In 2017, the global Community Acquired Pneumonia (CAP) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.<\/p>\n<p>This report focuses on the global Community Acquired Pneumonia (CAP) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Community Acquired Pneumonia (CAP) development in United States, Europe and China.<\/p>\n<p><strong>The key players covered<\/strong> in this study&nbsp;<br \/> <strong>Pfizer&nbsp;<br \/> Astrazeneca&nbsp;<br \/> Bioaegis Therapeutics&nbsp;<br \/> Biotest&nbsp;<br \/> C10 Pharma&nbsp;<br \/> Kyorin Pharmaceutical&nbsp;<br \/> Melinta Therapeutics&nbsp;<br \/> Merck&nbsp;<br \/> Nabriva Therapeutics&nbsp;<br \/> Paratek Pharmaceuticals<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<strong>Request For Sample Report<\/strong> @ <a rel=\"nofollow\" href=\"https:\/\/www.wiseguyreports.com\/sample-request\/3470656-global-community-acquired-pneumonia-cap-market-size-status-and-forecast-2018-2025\">https:\/\/www.wiseguyreports.com\/sample-request\/3470656-global-community-acquired-pneumonia-cap-market-size-status-and-forecast-2018-2025<\/a> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/p>\n<p>&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/p>\n<p><strong>Market segment by Type<\/strong>, the product can be split into&nbsp;<br \/> Chest X-ray\/Radiography&nbsp;<br \/> Sputum Gram Stain and\/or Culture&nbsp;<br \/> Blood Cultures<\/p>\n<p><strong>Market segment by Application<\/strong>, split into&nbsp;<br \/> Hospitals and Clinics&nbsp;<br \/> Others<\/p>\n<p><strong>Market segment by Regions\/Countries<\/strong>, this report covers&nbsp;<br \/> United States&nbsp;<br \/> Europe&nbsp;<br \/> China&nbsp;<br \/> Japan&nbsp;<br \/> Southeast Asia&nbsp;<br \/> India&nbsp;<br \/> Central &amp; South America<\/p>\n<p><strong>The study objectives of this report are:&nbsp;<br \/> <\/strong>To analyze global Community Acquired Pneumonia (CAP) status, future forecast, growth opportunity, key market and key players.&nbsp;<br \/> To present the Community Acquired Pneumonia (CAP) development in United States, Europe and China.&nbsp;<br \/> To strategically profile the key players and comprehensively analyze their development plan and strategies.&nbsp;<br \/> To define, describe and forecast the market by product type, market and key regions.<\/p>\n<p><strong>&nbsp;<\/strong><\/p>\n<p><strong>Complete Report Details @ <\/strong><a rel=\"nofollow\" href=\"https:\/\/www.wiseguyreports.com\/reports\/3470656-global-community-acquired-pneumonia-cap-market-size-status-and-forecast-2018-2025\">https:\/\/www.wiseguyreports.com\/reports\/3470656-global-community-acquired-pneumonia-cap-market-size-status-and-forecast-2018-2025<\/a> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Table Of Contents: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<\/strong><\/p>\n<p><strong>1 Report Overview&nbsp;<br \/> 1.1 Study Scope&nbsp;<br \/> 1.2 Key Market Segments&nbsp;<br \/> 1.3 Players Covered&nbsp;<br \/> 1.4 Market Analysis by Type&nbsp;<br \/> <\/strong>1.4.1 Global Community Acquired Pneumonia (CAP) Market Size Growth Rate by Type (2013-2025)&nbsp;<br \/> 1.4.2 Chest X-ray\/Radiography&nbsp;<br \/> 1.4.3 Sputum Gram Stain and\/or Culture&nbsp;<br \/> 1.4.4 Blood Cultures&nbsp;<br \/> <strong>1.5 Market by Application&nbsp;<br \/> <\/strong>1.5.1 Global Community Acquired Pneumonia (CAP) Market Share by Application (2013-2025)&nbsp;<br \/> 1.5.2 Hospitals and Clinics&nbsp;<br \/> 1.5.3 Others&nbsp;<br \/> <strong>1.6 Study Objectives&nbsp;<br \/> 1.7 Years Considered<\/strong><\/p>\n<p><strong>2 Global Growth Trends&nbsp;<br \/> <\/strong>2.1 Community Acquired Pneumonia (CAP) Market Size&nbsp;<br \/> 2.2 Community Acquired Pneumonia (CAP) Growth Trends by Regions&nbsp;<br \/> 2.2.1 Community Acquired Pneumonia (CAP) Market Size by Regions (2013-2025)&nbsp;<br \/> 2.2.2 Community Acquired Pneumonia (CAP) Market Share by Regions (2013-2018)&nbsp;<br \/> 2.3 Industry Trends&nbsp;<br \/> 2.3.1 Market Top Trends&nbsp;<br \/> 2.3.2 Market Drivers&nbsp;<br \/> 2.3.3 Market Opportunities<\/p>\n<p><strong>&hellip;..<\/strong><\/p>\n<p><strong>12 International Players Profiles&nbsp;<br \/> 12.1 Pfizer&nbsp;<br \/> <\/strong>12.1.1 Pfizer Company Details&nbsp;<br \/> 12.1.2 Company Description and Business Overview&nbsp;<br \/> 12.1.3 Community Acquired Pneumonia (CAP) Introduction&nbsp;<br \/> 12.1.4 Pfizer Revenue in Community Acquired Pneumonia (CAP) Business (2013-2018)&nbsp;<br \/> 12.1.5 Pfizer Recent Development&nbsp;<br \/> <strong>12.2 Astrazeneca&nbsp;<br \/> <\/strong>12.2.1 Astrazeneca Company Details&nbsp;<br \/> 12.2.2 Company Description and Business Overview&nbsp;<br \/> 12.2.3 Community Acquired Pneumonia (CAP) Introduction&nbsp;<br \/> 12.2.4 Astrazeneca Revenue in Community Acquired Pneumonia (CAP) Business (2013-2018)&nbsp;<br \/> 12.2.5 Astrazeneca Recent Development&nbsp;<br \/> <strong>12.3 Bioaegis Therapeutics&nbsp;<br \/> <\/strong>12.3.1 Bioaegis Therapeutics Company Details&nbsp;<br \/> 12.3.2 Company Description and Business Overview&nbsp;<br \/> 12.3.3 Community Acquired Pneumonia (CAP) Introduction&nbsp;<br \/> 12.3.4 Bioaegis Therapeutics Revenue in Community Acquired Pneumonia (CAP) Business (2013-2018)&nbsp;<br \/> 12.3.5 Bioaegis Therapeutics Recent Development&nbsp;<br \/> <strong>12.4 Biotest&nbsp;<br \/> <\/strong>12.4.1 Biotest Company Details&nbsp;<br \/> 12.4.2 Company Description and Business Overview&nbsp;<br \/> 12.4.3 Community Acquired Pneumonia (CAP) Introduction&nbsp;<br \/> 12.4.4 Biotest Revenue in Community Acquired Pneumonia (CAP) Business (2013-2018)&nbsp;<br \/> 12.4.5 Biotest Recent Development&nbsp;<br \/> <strong>12.5 C10 Pharma&nbsp;<br \/> <\/strong>12.5.1 C10 Pharma Company Details&nbsp;<br \/> 12.5.2 Company Description and Business Overview&nbsp;<br \/> 12.5.3 Community Acquired Pneumonia (CAP) Introduction&nbsp;<br \/> 12.5.4 C10 Pharma Revenue in Community Acquired Pneumonia (CAP) Business (2013-2018)&nbsp;<br \/> 12.5.5 C10 Pharma Recent Development&nbsp;<\/p>\n<p><strong>&nbsp;<\/strong><\/p>\n<p><strong>&nbsp;Continued&hellip;&hellip;.<\/strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> Wiseguyreports.com<br \/><strong>Contact Person:<\/strong> Norah Trent<br \/><strong>Email:<\/strong> <a href='http:\/\/www.universalpressrelease.com\/?pr=community-acquired-pneumonia-cap-global-market-analysis-growth-opportunities-top-key-players-and-forecast-to-2025&#038;type=pra'>Send Email<\/a><br \/><strong>Phone:<\/strong> +1 646 845 9349, +44 208 133 9349<br \/><strong>City:<\/strong> Pune<br \/><strong>State:<\/strong> Maharashtra<br \/><strong>Country:<\/strong> India<br \/><strong>Website:<\/strong> <a href=\"http:\/\/www.wiseguyreports.com\" target=\"_blank\" rel=\"nofollow\">www.wiseguyreports.com<\/a><\/p>\n<p><object type=\"text\/html\" data=\"http:\/\/www.wiseguyreports.com\" style=\"width:605px; height:400px;\"><\/object><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=community-acquired-pneumonia-cap-global-market-analysis-growth-opportunities-top-key-players-and-forecast-to-2025\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;Community Acquired Pneumonia (CAP) Market&#8221; WiseGuyRerports.com Presents \u201cGlobal Community Acquired Pneumonia (CAP) Market Size, Status and Forecast 2018-2025\u201d New Document to its Studies Database &nbsp; Community-acquired pneumonia (CAP) refers to pneumonia (any of several lung diseases) contracted by a person &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/community-acquired-pneumonia-cap-global-market-analysis-growth-opportunities-top-key-players-and-forecast-to-2025_283127.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-283127","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/283127","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=283127"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/283127\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=283127"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=283127"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=283127"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}